2Baumann MH, Nolan R, Petrini M, et al. Pleural tuberculosis in the United States :incidence and drug resistance[J]. Chest, 2007,131 (4) : 1125-1132.
3Bielsa S, Palma R, Pardina M, et al. Comparison of polymorphonuclearand lymphocyte-rich tuberculous pleural effusions[J]. Int J Tuberc Lung Dis, 2013,17( 1 ) : 85-89.
4Moore DA, Evans CA, Gilman RH, et al. Microscopic-observation drugsusceptibility assay for the diagnosis of TB[J]. N Engl J Med,2006,355 (15) : 1539-1550.
5Conde MB, Loivos AC, Rezende VM, et al. Yield of sputum induction in the diagnosis of pleural tuberculosis[J]. Am J Respir Crit Care Med, 2003, 167(5) ) :723-725.
6Porcel JM. Pleural fluid biomarkers: beyond the Light criteria[J]. Clin Chest Med, 2013,34 ( 1 ) : 27-37.
7Steingart KR, Sohn H, Schiller I. Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in aduhs[J/CD]. Cochrane Database Syst Rev, 2013,1 : CD009593.
8Lusiba JK, Nakiyingi L, Kirenga B J, et al. Evaluation of Cepheid's Xpert MTB/Rif test on pleural fluid in the diagnosis of pleural tuberculosis in a high prevalenceHIV/TB setting[J]. PLoS One ,201d ,9(7) :e102702.
9Christopher DJ, Schumacher SG, Michael JS, et al. Performance of Xpert MTB/RIF on pleural tissue for the diagnosis of pleural tuberculosis[J]. Eur Respir J,2013,42(5 ) : 1427-1429.
10Liang QL, Shi HZ, Wang K. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy : a meta-analysis [J]. Respir Med, 2008,102 (5) : 744-754.
2Carrara S, Vincenti D, Petrosillo N, et al. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy [ J ]. Clin Infect Dis, 2004, 38(5) : 754 -756.
3Wilkinson KA, Wilkinson R J, Pathan A, et al. Ex Vivo Charac- terization of Early Secretory Antigenic Target 6-Specific T Ceils at Sites of Active Disease in Pleural Tuberculosis [ J ]. Clin Infect Dis, 2005, 40(1) :184 -187.
4Lsoi M, Bossink A, Codecasa L, et al. Use of a T-cell interferon- gamma release assay for the diagnosis of tuberculous pleurisy [ J ]. Eur Respir J, 2007, 30 (6) : 1173 - 1179.
